These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 30663025)

  • 21. Performance of diffusion-weighted magnetic resonance imaging at 3.0T for early assessment of tumor response in locally advanced rectal cancer treated with preoperative chemoradiation therapy.
    Delli Pizzi A; Cianci R; Genovesi D; Esposito G; Timpani M; Tavoletta A; Pulsone P; Basilico R; Gabrielli D; Rosa C; Caravatta L; Di Tommaso M; Caulo M; Filippone A
    Abdom Radiol (NY); 2018 Sep; 43(9):2221-2230. PubMed ID: 29332248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of b800 and b1500 DWI-MRI of the pelvis to detect residual rectal adenocarcinoma: a multi-reader study.
    Bates DDB; Golia Pernicka JS; Fuqua JL; Paroder V; Petkovska I; Zheng J; Capanu M; Schilsky J; Gollub MJ
    Abdom Radiol (NY); 2020 Feb; 45(2):293-300. PubMed ID: 31690966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Application value of texture analysis of magnetic resonance images in prediction of neoadjuvant chemoradiotherapy efficacy for rectal cancer].
    Shu Z; Fang S; Ding Z; Mao D; Pang P; Gong X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1051-1058. PubMed ID: 30269327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The value of diffusion kurtosis magnetic resonance imaging for assessing treatment response of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
    Yu J; Xu Q; Song JC; Li Y; Dai X; Huang DY; Zhang L; Li Y; Shi HB
    Eur Radiol; 2017 May; 27(5):1848-1857. PubMed ID: 27631106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
    Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
    Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
    Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
    [No Abstract]   [Full Text] [Related]  

  • 27. MRI prediction of pathological response in locally advanced rectal cancer: when apparent diffusion coefficient radiomics meets conventional volumetry.
    Palmisano A; Di Chiara A; Esposito A; Rancoita PMV; Fiorino C; Passoni P; Albarello L; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2020 Oct; 75(10):798.e1-798.e11. PubMed ID: 32712007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MR Imaging with Apparent Diffusion Coefficient Histogram Analysis: Evaluation of Locally Advanced Rectal Cancer after Chemotherapy and Radiation Therapy.
    Enkhbaatar NE; Inoue S; Yamamuro H; Kawada S; Miyaoka M; Nakamura N; Sadahiro S; Imai Y
    Radiology; 2018 Jul; 288(1):129-137. PubMed ID: 29558294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
    Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
    Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
    Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
    Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of functional magnetic resonance imaging in predicting outcomes of neoadjuvant chemoradiotherapy in rectal cancer].
    Yu Y; Yue J; Yu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 May; 20(5):491-494. PubMed ID: 28534322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Kim SH; Lee JM; Park HS; Eun HW; Han JK; Choi BI
    J Magn Reson Imaging; 2009 May; 29(5):1093-101. PubMed ID: 19388124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The accuracy of endorectal ultrasonography and high-resolution magnetic resonance imaging for restaging rectal cancer after neoadjuvant chemoradiotherapy.
    Cote A; Florin FG; Mois E; Elisei R; Badea R; Mare C; Hajjar NA; Iancu C; Lebovici A
    Ann Ital Chir; 2018; 89():168-176. PubMed ID: 29848812
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to neoadjuvant chemoradiotherapy for locally advanced rectum cancer: Texture analysis of dynamic contrast-enhanced MRI.
    Zou HH; Yu J; Wei Y; Wu JF; Xu Q
    J Magn Reson Imaging; 2019 Mar; 49(3):885-893. PubMed ID: 30079601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
    Fahmawi Y; Smith C; Grimm L; Khullar S; Rider P; Hunter J; Iliff G; Mneimneh W; Roveda K; Wang B; Prodduturvar P; Alkharabsheh O; McCormick B; Mizrahi M; Khushman M
    Clin Colorectal Cancer; 2020 Dec; 19(4):e281-e287. PubMed ID: 32694005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma.
    Hall WA; Li J; You YN; Gollub MJ; Grajo JR; Rosen M; dePrisco G; Yothers G; Dorth JA; Rahma OE; Russell MM; Gross HM; Jacobs SA; Faller BA; George S; Al Baghdadi T; Haddock MG; Valicenti R; Hong TS; George TJ
    J Clin Oncol; 2023 Oct; 41(29):4643-4651. PubMed ID: 37478389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
    Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
    Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined artificial intelligence and radiologist model for predicting rectal cancer treatment response from magnetic resonance imaging: an external validation study.
    Horvat N; Veeraraghavan H; Nahas CSR; Bates DDB; Ferreira FR; Zheng J; Capanu M; Fuqua JL; Fernandes MC; Sosa RE; Jayaprakasam VS; Cerri GG; Nahas SC; Petkovska I
    Abdom Radiol (NY); 2022 Aug; 47(8):2770-2782. PubMed ID: 35710951
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restaging of rectal cancer with hybrid positron emission tomography magnetic resonance imaging after preoperative chemoradiotherapy.
    Tey J; Tan JK; Tan KK; Soon YY; Loi HY; Mohamed JSA; Bakulbhai PA; Ang B; Liang TY
    Ann Acad Med Singap; 2023 Jun; 52(6):289-295. PubMed ID: 38904510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting the response to neoadjuvant chemoradiation for rectal cancer using nomograms based on MRI tumour regression grade.
    Qin S; Chen Y; Liu K; Li Y; Zhou Y; Zhao W; Xin P; Wang Q; Lu S; Wang H; Lang N
    Cancer Radiother; 2024 Aug; 28(4):341-353. PubMed ID: 38981746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.